- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05695885
STEPS Implementation Trial
August 14, 2024 updated by: Susan White, University of Alabama, Tuscaloosa
Stepped Transition in Education Program for Emerging Adults With Autism: Pilot Effectiveness Trial
This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD).
The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencies.
Results will provide information on the effectiveness of the program as well as on mechanisms of change and contextual factors that promote or impede implementation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The long-term goal of this research is to improve adult outcomes for people with autism spectrum disorder (ASD).
Autistic adolescents and young adults tend to have worse outcomes with respect to employment, education, and quality of life, than neurotypical peers.
These outcomes include under-enrollment into college, unemployment, and limited functional independence.
Research-informed transition planning that addresses core impairments in skills related to adult autonomy, including self-knowledge, self-determination, and self-regulation, may improve outcomes for this growing population.
In prior research, investigators developed a stakeholder involved transition program (STEPS) and found it to be feasible, acceptable, and efficacious.
Data from a small randomized controlled trial (RCT) focusing on feasibility indicated that it was acceptable to participants and suggested STEPS was effective in improving readiness for transition to adulthood.
The team will now test the effectiveness of STEPS, and engagement of target mechanisms, in partnership with four community agencies.
This study is designed as a Hybrid Type 1, which focuses primarily on intervention effectiveness with a secondary focus on factors related to implementation.
Immediate (post-treatment) and longer-term (six month follow-up) clinical outcomes of adult functional outcomes and vocational engagement will be assessed.
The degree to which STEPS leads to change in the theoretical mediating mechanisms (i.e., adult autonomy skills) will be examined, as well as a formal test of mediation (i.e., the degree to which change in adult autonomy skills leads to change in adult functional outcomes).
Providers will provide qualitative information on implementation such as thoughts on STEPS' cultural sensitivity, and quantitative data on the appropriateness, feasibility, and acceptability of STEPS.
Providers' sustained use of STEPS with clients in the six months after study enrollment has ended will also be tracked.
This research will produce findings that have the potential to shift clinical practice related to transition to adulthood for people with ASD.
In light of the fact that approximately 70,000 people with ASD age into adulthood every year and the economic burden associated with ASD, the potential public health impact of this research is considerable.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Susan W White, PhD
- Phone Number: 2053481967
- Email: swwhite1@ua.edu
Study Contact Backup
- Name: Nicole Powell, PHD
- Phone Number: 2053483535
- Email: npowell@ua.edu
Study Locations
-
-
Alabama
-
Tuscaloosa, Alabama, United States, 35487
- Recruiting
- Center o=for Youth Development and Intervention
-
Contact:
- Susan W White, PhD
- Phone Number: 205-348-1967
- Email: swwhite1@ua.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 16-25 years of age
- have confirmed diagnosis of ASD
- want to participate in STEPS
- have a caregiver/parent who can complete assessments
Exclusion Criteria:
- presence of suicidal/homicidal intent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: STEPS
14 session counseling targeting adult independence skills
|
behavioral counseling
|
|
Other: Control
Services as usual
|
behavioral counseling normally provided
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transition Readiness Scale-Revised
Time Frame: 30 days
|
This caregiver and self-report questionnaire has a range of possible scores from 30 to 120, with higher scores indicating greater readiness.assigned
condition.
Scores are categorical in nature: 0 = no evidence of progression toward goals, 1 = some evidence, 2 = strong evidence of progression toward goals.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relationships, Employment, Autonomy, and Life Satisfaction
Time Frame: 30 days
|
This is a questionnaire completed by caregiver and participant.
Higher scores indicate greater autonomy, independence, and satisfaction.
On the self-report measure scores range as follows for Frequency: social engagement (0-56), outside meaningful activities (0-32), self-care (0-88), independence (0-56), and romance (0-16) and level of support ranges are: social engagement (0-68), outside meaningful activities (0-32), self-care (0-76), independence (0-48), finances (0-12), and satisfaction (0-132).
On caregiver-report, frequency subscales range as follows: degree of social contact (0-28), social initiation (0-60), work/finances (0-64), autonomy (0-56), care of self and home (0-72), and support subscales range as follows: social engagement (0-68), self-care (0-144), work activity (0-28), independence (0-16), and finances (0-24).
|
30 days
|
|
Rehabilitation Success
Time Frame: 30 days
|
This brief interview on progress made toward educational or employment goals is completed with participant and caregiver, conducted by an examiner unaware of assigned condition.
Scores are categorical in nature: 0 = no evidence of progress toward goals, 1 = some evidence of progress toward goals, 2 = moderate evidence of progress toward goals, and 3 = clear strong evidence of progress toward goals.
Higher scores indicate greater goal attainment.
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Estimated)
March 31, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
January 13, 2023
First Submitted That Met QC Criteria
January 13, 2023
First Posted (Actual)
January 25, 2023
Study Record Updates
Last Update Posted (Actual)
August 16, 2024
Last Update Submitted That Met QC Criteria
August 14, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-07-5746
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
we submit de-identified data to NIH repository (NDA)
IPD Sharing Time Frame
one year after study closure
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on STEPS
-
University of Texas at AustinCompleted
-
Guangzhou General Hospital of Guangzhou Military...The First Affiliated Hospital of Guangzhou Medical University; Medical Center...CompletedOsteoarthritis | Osteoarthritis, KneeChina
-
University of MichiganEmory University; Ann & Robert H Lurie Children's Hospital of Chicago; Harvard...Completed
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
University of Alabama, TuscaloosaRecruitingAutism Spectrum DisorderUnited States
-
Virginia Polytechnic Institute and State UniversityUniversity of Alabama at BirminghamCompletedAutism Spectrum DisorderUnited States
-
McMaster UniversityCanadian Diabetes AssociationCompleted
-
Duke UniversityCompleted
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdolescent and Young Adult (AYA) Cancer SurvivorsUnited States
-
Beth Israel Deaconess Medical CenterCompleted